Cargando…
Global and Regional Effects of Bladder Cancer Risk Associated with Pioglitazone Therapy in Patients with Diabetes
It has been debated for several years as to whether the antidiabetic drug pioglitazone increases the risk for bladder cancer. A series of recent large population studies yielded conflicting results. To investigate why the observational studies yielded conflicting results, we conducted stratified ana...
Autores principales: | Qu, Hua, Zheng, Yi, Wang, Yuren, Zhang, Rui, Ruan, Xiongzhong, Yang, Gangyi, Liu, Zhenqi, Zheng, Hongting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694000/ https://www.ncbi.nlm.nih.gov/pubmed/29150684 http://dx.doi.org/10.1038/s41598-017-16074-1 |
Ejemplares similares
-
Mitochondrial glycerol 3‐phosphate dehydrogenase promotes skeletal muscle regeneration
por: Liu, Xiufei, et al.
Publicado: (2018) -
The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone
por: Song, Sun Ok, et al.
Publicado: (2012) -
Pioglitazone use in patients with diabetes and risk of bladder cancer: a systematic review and meta-analysis
por: Yan, Huaqing, et al.
Publicado: (2018) -
The Risk of Bladder Cancer in Type 2 Diabetes Mellitus with Combination Therapy of SGLT-2 Inhibitors and Pioglitazone
por: Li, Yan-Rong, et al.
Publicado: (2021) -
Pioglitazone Use and Risk of Bladder Cancer: an In Vitro Study
por: Yang, Shao-ling, et al.
Publicado: (2018)